Palisade Bio, Inc. (PALI)
2.105
+0.12
(+5.78%)
USD |
NASDAQ |
May 27, 14:03
Palisade Bio Free Cash Flow : -12.40M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 107.55M |
| ACADIA Pharmaceuticals, Inc. | 113.59M |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Amgen, Inc. | 8.597B |
| Savara, Inc. | -106.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.89M |
| Cash from Financing (Quarterly) | 3.133M |
| Free Cash Flow Per Share (Quarterly) | -0.0186 |
| Free Cash Flow to Equity (Quarterly) | -3.819M |
| Free Cash Flow to Firm (Quarterly) | -3.889M |
| Free Cash Flow Yield | -6.18% |